why not use dpp4 and glp 1 together Dipeptidyl Peptidase 4 Inhibitors: Novel Therapeutic Agents in the Management of Type II Diabetes Mellitus 𝐋𝐚𝐭𝐞𝐬𝐭 𝐩𝐨𝐬𝐢𝐭𝐢𝐨𝐧 𝐨𝐟 𝐃𝐏𝐏-𝟒 𝐢𝐧𝐡𝐢𝐛𝐢𝐭𝐨𝐫𝐬

This blockade leads to rapid accumulation of norepinephrine within the synaptic cleft and prolonged activation of postsynaptic adrenergic receptors, producing enhanced sympathomimetic activity

Even more, the regulatory story adds a cautionary note

The total average investment for a full course of treatment is approximately $56,640

Saxenda, Wegovy and Zepbound are all GLP-1 receptor agonists that work by stimulating the GLP-1 receptor in the brain to help people feel full

Of course, it would be un-tidy to single arrhythmias out, in view of the high percentage of sudden deaths among the pimobendan group in the EPIC Study

& Hashimoto, K